HomeNewsBusinessIPOIdeas For Profit | Cadila: COVID opportunity, complex pharma pipeline offer strong risk reward

Ideas For Profit | Cadila: COVID opportunity, complex pharma pipeline offer strong risk reward

Cadila’s stock was primed by a series of potential roll outs to meet the COVID-19 challenge. Beyond COVID, the company is steadily building up its injectable and biosimilars portfolio - the areas to look at for the longer term.

May 28, 2021 / 19:12 IST
Story continues below Advertisement

Moneycontrol News
first published: May 28, 2021 07:12 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!